Key Account Manager
No salary listed
Senior
Tokyo, Japan
In PersonATS workplace is Tokyo, Japan; the role is identified as field work.
Sales & Account ManagementAccount Management
About the job
Requirements
- Hold a certified Medical Representative (MR) qualification.
- Have at least 8 years of experience in MR or Sales functions at a pharmaceutical company.
- Have experience as an MR at a pharmaceutical company leading pharmaceutical wholesaler initiatives, collaborating with wholesalers, directing distribution strategy, and achieving results in new product adoption and account opening.
- Have experience managing key accounts such as university hospitals and core hospitals, achieving strong results with spillover effects at affiliated facilities and across the region.
- Have experience leading teams or projects and achieving strong results.
- Be able to think logically and rationally in alignment with business issues and objectives, and act nimbly.
- Have communication, coordination, and negotiation skills when engaging internal and external stakeholders.
- Act proactively for the team and organization.
- Comply with regulations, act ethically, and be accountable.
Responsibilities
- Execute head-office brand strategy at assigned key accounts and maximize product value.
- Support execution of head-office brand strategy in the area and maximize product value.
- Lead the rapid market introduction of biopharmaceuticals, including biosimilars.
- Understand adoption processes for biosimilars and biosimilars-equivalent products at assigned key accounts, provide appropriate information to decision-makers, and conduct adoption activities.
- Plan and execute business plans for assigned key accounts.
- Work closely with Biosimilars Business Unit MRs and participate in and support area account management.
- Coordinate with Finance & Strategy Distribution Policy and strongly promote pharmaceutical wholesaler initiatives across the area.
- Coordinate with Marketing and Medical Affairs to optimize brand performance.
- Promote information sharing as the liaison with other business units and lead cross-functional collaboration.
- Plan and execute strategies for peer-to-peer programs, including web seminars and related academic conferences.
- Report directly to the Biosimilars Business Unit Sales Department District Sales Manager.
Desired Qualifications
- Experience as a key account manager at a pharmaceutical company.
- Experience handling distribution policy or designated wholesalers at a pharmaceutical company.
- People-management experience.
- MR experience with biopharmaceuticals, including biosimilars and biosimilars-equivalent products.
About the company
Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.
Company Size
10,001+
Company Stage
IPO
Headquarters
Thousand Oaks, California
Founded
1980
Get referred to Amgen
See people who can refer or advise you
Simplify's Take
What believers are saying
- Growth is broad-based: 22 products grew at least 10%, lifting June 2026 quarter revenue 10% to $10.1 billion.
- Stock grants gained value: Amgen shares rose 27% from January to October 9, 2026, versus 10% for rival Eli Lilly.
- Many U.S. roles are remote: 145 of Amgen's 615 U.S. job openings in October 2026 were fully remote.
What critics are saying
- Its 2025 best seller is shrinking: cheaper copies cut bone drug Prolia's sales 32% in the June 2026 quarter.
- MariTide, Amgen's obesity bet, faces a giant: Lilly's Mounjaro and Zepbound outsold all of Amgen in the June 2026 quarter.
- Most tech openings are in India: 156 of Amgen's 210 information systems jobs in October 2026 were in Hyderabad.
What makes Amgen unique
- It copies rivals' blockbusters too: Pavblu, its version of Regeneron's eye drug Eylea, sold $700 million in 2025.
- Amgen hunts drug targets in a nation's DNA: its Icelandic unit deCODE has genetic data on two-thirds of Iceland's adults.
- Amgen opened a U.S. cancer-drug class: Blincyto, approved in 2014, was the first to tether immune cells to cancer.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Professional Development Budget
- Conference Attendance Budget